Keppra and Tradjenta drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Keppra (levetiracetam) and Tradjenta (linagliptin). Common drug interactions include erythema among females and cerebrovascular accident among males.

The phase IV clinical study analyzes what interactions people have when they take Keppra and Tradjenta. It is created by eHealthMe based on reports of 50 people who take the same drugs from the FDA, and is updated regularly.

What is Keppra?

Keppra has active ingredients of levetiracetam. It is often used in epilepsy. eHealthMe is studying from 73,504 Keppra users. Check the latest studies of Keppra.

What is Tradjenta?

Tradjenta has active ingredients of linagliptin. It is often used in diabetes. eHealthMe is studying from 9,987 Tradjenta users. Check the latest studies of Tradjenta.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 29, 2026

50 people who take Keppra and Tradjenta together, and have interactions are studied.

Keppra and Tradjenta drug interactions.

What are the common drug interactions of Keppra and Tradjenta, by gender? *:

female:

  1. Erythema (redness of the skin)
  2. Fall
  3. Feeling hot
  4. Fungal infection
  5. Gait disturbance
  6. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  7. Headache (pain in head)
  8. Hot flush (sudden feelings of heat)
  9. Hyperhidrosis (abnormally increased sweating)
  10. Hypophagia (reduced food intake)

male:

  1. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  2. Aortic valve replacement
  3. Tooth infection
  4. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  5. Abdominal pain
  6. Acute respiratory failure
  7. Anaemia (lack of blood)
  8. Aortic aneurysm (enlargement of an aortic artery caused by a weakening of the artery wall)
  9. Blood glucose decreased
  10. Blood glucose increased

What are the common drug interactions of Keppra and Tradjenta, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Hyperlipidaemia (presence of excess lipids in the blood)
  2. Hypertension (high blood pressure)
  3. Inflammation
  4. Migraine (headache)
  5. Pneumonia
  6. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  7. Anxiety
  8. Chronic kidney disease
  9. Emotional distress
  10. Epistaxis (bleed from the nose)

50-59:

  1. Anaemia (lack of blood)
  2. Hypotension (abnormally low blood pressure)
  3. Neuropathy peripheral (surface nerve damage)
  4. Restless legs syndrome (a powerful urge to move your legs)
  5. Weight decreased
  6. Knee arthroplasty
  7. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  8. Pneumonia
  9. Aortic aneurysm (enlargement of an aortic artery caused by a weakening of the artery wall)
  10. Death

60+:

  1. Asthenia (weakness)
  2. Dizziness
  3. Death
  4. Diabetic ketoacidosis (diabetic ketoacidosis (dka) is high concentrations of ketone bodies)
  5. Fatigue (feeling of tiredness)
  6. Nephrolithiasis (calculi in the kidneys)
  7. Tooth infection
  8. Urosepsis (secondary infection that occurs when a urinary tract infection spreads to the bloodstream)
  9. Syncope (loss of consciousness with an inability to maintain postural tone)
  10. Abdominal pain upper

What are the existing conditions these people have? *

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 9 people, 18.00%
  2. Hyperkalemia (damage to or disease of the kidney): 6 people, 12.00%
  3. Type 2 Diabetes: 5 people, 10.00%
  4. Thyroid Diseases: 5 people, 10.00%
  5. Seizures (abnormal excessive or synchronous neuronal activity in the brain): 5 people, 10.00%
  6. High Blood Cholesterol: 5 people, 10.00%
  7. Stress And Anxiety: 4 people, 8.00%
  8. High Blood Pressure: 4 people, 8.00%
  9. Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 3 people, 6.00%
  10. Renal Cell Carcinoma (a kidney cancer): 3 people, 6.00%

* Approximation only. Some reports may have incomplete information.

Do you take Keppra and Tradjenta?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Keppra and Tradjenta:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Keppra:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Tradjenta:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Keppra and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Tradjenta and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on levetiracetam and linagliptin (the active ingredients of Keppra and Tradjenta, respectively), and Keppra and Tradjenta (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: